BioNexus Gene Lab (BGLC) Depreciation and Depletion (2018 - 2025)
BioNexus Gene Lab's Depreciation and Depletion history spans 8 years, with the latest figure at $28430.0 for Q4 2025.
- Quarterly results put Depreciation and Depletion at $28430.0 for Q4 2025, down 3.79% from a year ago — trailing twelve months through Dec 2025 was $111873.0 (up 7.4% YoY), and the annual figure for FY2025 was $111873.0, up 7.4%.
- Depreciation and Depletion for Q4 2025 was $28430.0 at BioNexus Gene Lab, down from $29001.0 in the prior quarter.
- In the past five years, Depreciation and Depletion ranged from a high of $63129.0 in Q3 2023 to a low of -$20879.0 in Q2 2023.
- The 5-year median for Depreciation and Depletion is $22715.0 (2021), against an average of $24099.8.
- The sharpest move saw Depreciation and Depletion surged 254.67% in 2021, then tumbled 192.24% in 2023.
- Year by year, Depreciation and Depletion stood at $22794.0 in 2021, then rose by 8.88% to $24819.0 in 2022, then dropped by 18.99% to $20106.0 in 2023, then skyrocketed by 46.97% to $29549.0 in 2024, then decreased by 3.79% to $28430.0 in 2025.
- According to Business Quant data, Depreciation and Depletion over the past three periods came in at $28430.0, $29001.0, and $27800.0 for Q4 2025, Q3 2025, and Q2 2025 respectively.